---  
layout: startup_page  
title: "Solu Therapeutics"  
id: "solutherapeutics.com"  
permalink: "/solutherapeuticssolutherapeutics.com04092025/"  
website: "https://www.solutherapeutics.com"  
funding_round: "Series A"  
funding_amount: "$41M"  
investors: "Eli Lilly and Company, Biovision Ventures, Pappas Capital, Hengdian Group Capital (HgC), The Leukemia & Lymphoma Society Therapy Acceleration Program, Longwood Fund, DCVC Bio, Sant√© Ventures, Astellas Venture Management, Alexandria Venture Investments"  
about: "Solu Therapeutics is a biotechnology company developing therapies to eliminate disease-driving cells in various therapeutic areas. They utilize proprietary CyTAC and TicTAC platforms to create targeted therapies, with their lead product candidate, STX-0712, currently in Phase 1 clinical trials for hematologic malignancies."  
markets: "Biotechnology, Oncology, Immunology"  
hq: "Boston, Massachusetts, United States"  
founded_year: "2022"  
linkedin: "https://www.linkedin.com/company/solu-therapeutics"  
twitter: "https://twitter.com/Solu_Tx"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/solu-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/529171-75"  

date_display: "09-Apr-2025"  
date: "2025-04-09"

# SEO Optimization  
meta_title: "Solu Therapeutics - Series A Funding ($41M)"  
meta_description: "Solu Therapeutics, Solu Therapeutics is a biotechnology company developing therapies to eliminate disease-driving cells in various therapeutic areas. They utilize propri..."  
meta_keywords: "Solu Therapeutics, Biotechnology, Oncology, Immunology, Series A funding"  
canonical_url: "https://startup.projectstartups.com/solutherapeuticssolutherapeutics.com04092025/"  
---